Contribution of neutrophils to acute lung injury

Molecular Medicine

Volumn 17, Issue 3-4, 2011, Pages 293-307

  Grommes, Jochen ^a   Soehnlein, Oliver ^a,b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL CATIONIC PEPTIDE; AZUROCIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CHEMOKINE; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; CYTOKINE; DEFENSIN; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 1BETA; INTERLEUKIN 8; LACTOFERRIN; MATRIX METALLOPROTEINASE; OXIDIZING AGENT; PROTEINASE; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SELECTIN; SERINE PROTEINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR; UVOMORULIN; VASCULAR CELL ADHESION MOLECULE 1;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; ANTIMICROBIAL ACTIVITY; ARTICLE; CELL FUNCTION; CELL INFILTRATION; DISEASE COURSE; EXTRACELLULAR SPACE; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY INFILTRATE; LEUKOCYTE ACTIVATION; LUNG ALVEOLUS; LUNG INTERSTITIUM; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

ACUTE LUNG INJURY; ANIMALS; DISEASE PROGRESSION; HUMANS; LUNG; MODELS, IMMUNOLOGICAL; NEUTROPHIL INFILTRATION; NEUTROPHILS; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 79952827479     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00138     Document Type: Article

References (217)

1. Bernard GR, et al. (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am. J. Respir. Crit. Care Med. 149:818-24.
2. Ware LB, Matthay MA. (2000) The acute respiratory distress syndrome. N. Engl. J. Med. 342:1334-49.
3. Matute-Bello G, Frevert CW, Martin TR. (2008) Animal models of acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 295:L379-99.
4. Ware LB. (2006) Pathophysiology of acute lung injury and the acute respiratory distress syndrome. Semin. Respir. Crit. Care Med. 27:337-49.
5. Manicone AM. (2009) Role of the pulmonary epithelium and inflammatory signals in acute lung injury. Expert Rev. Clin. Immunol. 5:63-75.
6. Abraham E. (2003) Neutrophils and acute lung injury 619. Crit. Care Med. 31:S195-9.
7. Matthay MA, Eschenbacher WL, Goetzl EJ. (1984) Elevated concentrations of leukotriene D4 in pulmonary edema fluid of patients with the adult respiratory distress syndrome. J. Clin. Immunol. 4:479-83.
8. Parsons PE, Fowler AA, Hyers TM, Henson PM. (1985) Chemotactic activity in bronchoalveolar lavage fluid from patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 132:490-3.
9. Steinberg KP, et al. (1994) Evolution of bronchoalveolar cell populations in the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 150:113-22.
10. Abraham E, Carmody A, Shenkar R, Arcaroli J. (2000) Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:L1137-45.
11. Folkesson HG, Matthay MA, Hebert CA, Broaddus VC. (1995) Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J. Clin. Invest. 96:107-16.
12. Martin TR, Pistorese BP, Chi EY, Goodman RB, Matthay MA. (1989) Effects of leukotriene B4 in the human lung. Recruitment of neutrophils into the alveolar spaces without a change in protein permeability. J. Clin. Invest. 84:1609-19.
13. Laufe MD, Simon RH, Flint A, Keller JB. (1986) Adult respiratory distress syndrome in neutropenic patients. Am. J. Med. 80:1022-6.
14. Ognibene FP, et al. (1986) Adult respiratory distress syndrome in patients with severe neutropenia. N. Engl. J. Med. 315:547-51.
15. Sivan Y, Mor C, al-Jundi S, Newth CJ. (1990) Adult respiratory distress syndrome in severely neutropenic children. Pediatr. Pulmonol. 8:104-8.
16. Wiener-Kronish JP, Albertine KH, Matthay MA. (1991) Differential responses of the endothelial and epithelial barriers of the lung in sheep to Escherichia coli endotoxin. J. Clin. Invest. 88:864-75.
17. Wiggs BR, et al. (1994) Contributions of capillary pathway size and neutrophil deformability to neutrophil transit through rabbit lungs. J. Appl. Physiol. 77:463-70.
18. Knight PR, Druskovich G, Tait AR, Johnson KJ. (1992) The role of neutrophils, oxidants, and proteases in the pathogenesis of acid pulmonary injury. Anesthesiology. 77:772-8.
19. Kawano T, et al. (1987) Effect of granulocyte depletion in a ventilated surfactant-depleted lung. J. Appl. Physiol. 62:27-33.
20. Julien M, Hoeffel JM, Flick MR. (1986) Oleic acid lung injury in sheep. J. Appl. Physiol. 60:433-40.
21. O'Brien-Ladner AR, Nelson ME, Cowley BD Jr., Bailey K, Wesselius LJ. (1995) Hyperoxia amplifies TNF-alpha production in LPS-stimulated human alveolar macrophages. Am. J. Respir. Cell Mol. Biol. 12:275-9.
22. Shea LM, et al. (1996) Hyperoxia activates NFkappaB and increases TNF-alpha and IFNgamma gene expression in mouse pulmonary lymphocytes. J. Immunol. 157:3902-8.
23. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 7:678-89.
24. Doerschuk CM. (2000) Leukocyte trafficking in alveoli and airway passages. Respir. Res. 1:136-40.
25. Doerschuk CM, et al. (1987) Marginated pool of neutrophils in rabbit lungs. J. Appl. Physiol. 63:1806-15.
26. Tanaka H, Nishino M, Dahms TE. (2002) Physiologic responses to small emboli and hemodynamic effects of changes in deformability of polymorphonuclear leukocytes in isolated rabbit lung. Microvasc. Res. 63:81-90.
27. Doerschuk CM, Mizgerd JP, Kubo H, Qin L, Kumasaka T. (1999) Adhesion molecules and cellular biomechanical changes in acute lung injury: Giles F. Filley Lecture. Chest. 116:37-43S.
28. Worthen GS, Schwab B III, Elson EL, Downey GP. (1989) Mechanics of stimulated neutrophils: cell stiffening induces retention in capillaries. Science. 245:183-6.
29. Drost EM, MacNee W. (2002) Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis. Eur. J. Immunol. 32:393-403.
30. Motosugi H, et al. (1996) Changes in neutrophil actin and shape during sequestration induced by complement fragments in rabbits. Am. J. Pathol. 149:963-73.
31. Burns AR, Smith CW, Walker DC. (2003) Unique structural features that influence neutrophil emigration into the lung. Physiol. Rev. 83:309-36.
32. Furuse M, et al. (1994) Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J. Cell. Biol. 127:1617-26.
33. Su WH, Chen HI, Jen CJ. (2002) Differential movements of VE-cadherin and PECAM-1 during transmigration of polymorphonuclear leukocytes through human umbilical vein endothelium. Blood. 100:3597-603.
34. Carlow DA, et al. (2009) PSGL-1 function in immunity and steady state homeostasis. Immunological Reviews 230:75-96.
35. Laszik Z, et al. (1996) P-selectin glycoprotein ligand-1 is broadly expressed in cells of myeloid, lymphoid, and dendritic lineage and in some nonhematopoietic cells. Blood. 88:3010-21.
36. Mizgerd JP, et al. (1996) Selectins and neutrophil traffic: margination and Streptococcus pneumoniae- induced emigration in murine lungs. J. Exp. Med. 184:639-45.
37. Burns JA, Issekutz TB, Yagita H, Issekutz AC. (2001) The alpha 4 beta 1 (very late antigen (VLA)-4, CD49d/CD29) and alpha 5 beta 1 (VLA-5, CD49e/CD29) integrins mediate beta 2 (CD11/CD18) integrin-independent neutrophil recruitment to endotoxin-induced lung inflammation. J. Immunol. 166:4644-9.
38. Looney MR, et al. (2009) Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J. Clin. Invest. 119:3450-61.
39. Chandra A, et al. (2003) P-selectin blockade fails to improve acute lung injury in sheep. Clin. Sci. (Lond). 104:313-21.
40. Mulligan MS, Miyasaka M, Ward PA. (1996) Protective effects of combined adhesion molecule blockade in models of acute lung injury. Proc. Assoc. Am. Physicians. 108:198-208.
41. Mulligan MS, et al. (1993) Protective effects of oligosaccharides in P-selectin-dependent lung injury. Nature. 364:149-51.
42. Hirose M, Murai T, Kawashima H. (2007) Elevation of rat plasma P-selectin in acute lung injury. Biochim. Biophys. Acta. 1772:382-9.
43. Bock D, Aydt EM, Kuebler WM, Wolff G. (2006) The role of selectins during lung inflammation and their potential impact for innovative therapeutic strategies. Curr. Respir. Med. Rev. 2:339-54.
44. Hayashi H, Koike H, Kurata Y, Imanishi N, Tojo SJ. (1999) Protective effects of sialyl Lewis X and anti-P-selectin antibody against lipopolysaccharide- induced acute lung injury in rabbits. Eur. J. Pharmacol. 370:47-56.
45. Ridings PC, et al. (1995) Sepsis-induced acute lung injury is attenuated by selectin blockade following the onset of sepsis. Arch. Surg. 130:1199-208.
46. Doerschuk CM, et al. (1996) The role of P-selectin and ICAM-1 in acute lung injury as determined using blocking antibodies and mutant mice. J. Immunol. 157:4609-14.
47. Zarbock A, Singbartl K, Ley K. (2006) Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J. Clin. Invest. 116:3211-9.
48. Abram CL, Lowell CA. (2009) The ins and outs of leukocyte integrin signaling. Annu. Rev. Immunol. 27:339-62.
49. Hynes RO. (2002) Integrins: bidirectional, allosteric signaling machines. Cell. 110:673-87.
50. Kim S, Schein AJ, Nadel JA. (2005) E-cadherin promotes EGFR-mediated cell differentiation and MUC5AC mucin expression in cultured human airway epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 289: L1049-60.
51. Ganter MT, et al. (2008) Interleukin-1{beta} causes acute lung injury via {alpha}v{beta}5 and {alpha}v{beta}6 integrin-dependent mechanisms. Circ. Res. 102:804-12.
52. Song Y, et al. (2008) Role of integrin {alpha}v{beta}6 in acute lung injury induced by pseudomonas aeruginosa. Infect. Immun. 76:2325-32.
53. Xu J, et al. (2008) Nonmuscle myosin light-chain kinase mediates neutrophil transmigration in sepsis-induced lung inflammation by activating [beta]2 integrins. Nat. Immunol. 9:880-6.
54. Moreland JG, Fuhrman RM, Pruessner JA, Schwartz DA. (2002) CD11b and intercellular adhesion molecule-1 are involved in pulmonary neutrophil recruitment in lipopolysaccharideinduced airway disease. Am. J. Respir. Cell Mol. Biol. 27:474-80.
55. Mulligan M, et al. (1992) Roles of beta 2 integrins of rat neutrophils in complement- and oxygen radical-mediated acute inflammatory injury. J. Immunol. 148:1847-57.
56. Xu N, Rahman A, Minshall RD, Tiruppathi C, Malik AB. (2000) {beta}2-Integrin blockade driven by E-selectin promoter prevents neutrophil sequestration and lung injury in mice. Circ. Res. 87:254-60.
57. Hellewell PG, Young SK, Henson PM, Worthen GS. (1994) Disparate role of the beta 2-integrin CD18 in the local accumulation of neutrophils in pulmonary and cutaneous inflammation in the rabbit. Am. J. Respir. Cell Mol. Biol. 10:391-8.
58. Mizgerd JP, et al. (1997) Neutrophil emigration in the skin, lungs, and peritoneum: different requirements for CD11/CD18 revealed by CD18-deficient mice. J. Exp. Med. 186:1357-64.
59. Winn RK, et al. (1993) Role of protein synthesis and CD11/CD18 adhesion complex in neutrophil emigration into the lung. Exp. Lung Res. 19:221-35.
60. Doerschuk CM, Winn RK, Coxson HO, Harlan JM. (1990) CD18-dependent and -independent mechanisms of neutrophil emigration in the pulmonary and systemic microcirculation of rabbits. J. Immunol. 144:2327-33.
61. Puneet P, Moochhala S, Bhatia M. (2005) Chemo - kines in acute respiratory distress syndrome. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L3-15.
62. Miller EJ, Cohen AB, Matthay MA. (1996) Increased interleukin-8 concentrations in the pulmonary edema fluid of patients with acute respiratory distress syndrome from sepsis. Crit. Care Med. 24:1448-54.
63. Miller EJ, et al. (1992) Elevated levels of NAP-1/ interleukin-8 are present in the airspaces of patients with the adult respiratory distress syndrome and are associated with increased mortality. Am. Rev. Respir. Dis. 146:427-32.
64. Fudala R, Krupa A, Stankowska D, Allen TC, Kurdowska AK. (2008) Anti-interleukin-8 autoantibody:interleukin-8 immune complexes in acute lung injury/acute respiratory distress syndrome. Clin. Sci. (Lond). 114:403-12.
65. Allen TC, Fudala R, Nash SE, Kurdowska A. (2007) Anti-interleukin 8 autoantibody:interleukin 8 immune complexes visualized by laser confocal microscopy in injured lung. Arch. Pathol. Lab. Med. 131:452-6.
66. Kurdowska A, et al. (2002) Anti-interleukin-8 autoantibodies in patients at risk for acute respiratory distress syndrome. Crit. Care Med. 30:2335-7.
67. Kurdowska A, et al. (2001) Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity. Am. J. Respir. Crit. Care Med. 163:463-8.
68. Krupa A, Kato H, Matthay MA, Kurdowska AK. (2004) Proinflammatory activity of anti-IL-8 autoantibody: IL-8 complexes in alveolar edema fluid from patients with acute lung injury. Am. J. Physiol. Lung Cell Mol. Physiol. 286:L1105-13.
69. Yang XD, Corvalan JR, Wang P, Roy CM, Davis CG. (1999) Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states. J. Leukoc. Biol. 66:401-10.
70. Osman MO, et al. (1998) A monoclonal antiinterleukin 8 antibody (WS-4) inhibits cytokine response and acute lung injury in experimental severe acute necrotising pancreatitis in rabbits. Gut. 43:232-9.
71. Bao Z, Ye Q, Gong W, Xiang Y, Wan H. (2010) Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury. Int. Immunopharmacol. 10:259-63.
72. Laffon M, Pittet J-F, Modelska K, Matthay MA, Young DM. (1999) Interleukin-8 mediates injury from smoke inhalation to both the lung endothelial and the alveolar epithelial barriers in rabbits. Am. J. Respir. Crit. Care Med. 160:1443-9.
73. Sekido N, et al. (1993) Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8. Nature. 365:654-7.
74. Olson TS, Ley K. (2002) Chemokines and chemokine receptors in leukocyte trafficking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283:R7-28.
75. Zarbock A, Allegretti M, Ley K. (2008) Therapeutic inhibition of CXCR2 by Reparixin attenuates acute lung injury in mice. Br. J. Pharmacol. 155:357-64.
76. Bhatia M, Hegde A. (2007) Treatment with antileukinate, a CXCR2 chemokine receptor antagonist, protects mice against acute pancreatitis and associated lung injury. Regul. Pept. 138:40-8.
77. Lomas-Neira JL, Chung CS, Grutkoski PS, Miller EJ, Ayala A. (2004) CXCR2 inhibition suppresses hemorrhage-induced priming for acute lung injury in mice. J. Leukoc. Biol. 76:58-64.
78. Goncalves AS, Appelberg R. (2002) The involvement of the chemokine receptor CXCR2 in neutrophil recruitment in LPS-induced inflammation and in Mycobacterium avium infection. Scand. J. Immunol. 55:585-91.
79. Auten RL, et al. (2001) Nonpeptide CXCR2 antagonist prevents neutrophil accumulation in hyperoxia-exposed newborn rats. J. Pharmacol. Exp. Ther. 299:90-5.
80. Belperio JA, et al. (2005) CXCR2/CXCR2 ligand biology during lung transplant ischemiareperfusion injury. J. Immunol. 175:6931-9.
81. Belperio JA, et al. (2002) Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury. J. Clin. Invest. 110:1703-16.
82. Reutershan J, et al. (2006) Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J. Clin. Invest 116:695-702.
83. Stillie R, Farooq SM, Gordon JR, Stadnyk AW. (2009) The functional significance behind expressing two IL-8 receptor types on PMN. J. Leukoc. Biol. 86:529-43.
84. Chishti AD, et al. (2001) Expression of chemokine receptors CXCR1 and CXCR2 during cardiopulmonary bypass. J. Thorac. Cardiovasc. Surg. 122:1162-6.
85. Cummings CJ, et al. (1999) Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis. J. Immunol. 162:2341-6.
86. Mei J, et al. (2010) CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity. 33:106-17.
87. Reutershan J, Harry B, Chang D, Bagby GJ, Ley K. (2009) DARC on RBC limits lung injury by balancing compartmental distribution of CXC chemokines. Eur. J. Immunol. 39:1597-607.
88. Zhang H, Zhi L, Moochhala SM, Moore PK, Bhatia M. (2007) Endogenous hydrogen sulfide regulates leukocyte trafficking in cecal ligation and puncture-induced sepsis. J. Leukoc. Biol. 82:894-905.
89. Zhang H, Zhi L, Moore PK, Bhatia M. (2006) Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse. Am. J. Physiol. Lung Cell. Mol. Physiol. 290:L1193-201.
90. Perl M, et al. (2007) Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am. J. Respir. Crit. Care Med. 176:591-601.
91. Nathan CF. (1987) Secretory products of macrophages. J. Clin. Invest. 79:319-26.
92. Goodman RB, Pugin J, Lee JS, Matthay MA. (2003) Cytokine-mediated inflammation in acute lung injury. Cytokine Growth Factor Rev. 14:523-35.
93. Goodman RB, et al. (1996) Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154:602-11.
94. Park WY, et al. (2001) Cytokine balance in the lungs of patients with acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 164:1896-903.
95. Shimizu M, et al. (2009) Effects of TNF-alphaconverting enzyme inhibition on acute lung injury induced by endotoxin in the rat. Shock. 32:535-40.
96. Soares AL, et al. (2010) Tumor necrosis factor is not associated with intestinal ischemia/ reperfusion-induced lung inflammation. Shock. 34:306-13.
97. Hoshino T, et al. (2009) Role of proinflammatory cytokines IL-18 and IL-1{beta} in bleomycininduced lung injury in humans and mice. Am. J. Respir. Cell Mol. Biol. 41:661-70.
98. Borregaard N, Cowland JB. (1997) Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 89:3503-21.
99. Faurschou M, Borregaard N. (2003) Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 5:1317-27.
100. Soehnlein O, et al. (2008) Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein 172. Eur. Respir. J. 32:405-12.
101. Cochrane CG, Spragg RG, Revak SD, Cohen AB, McGuire WW. (1983) The presence of neutrophil elastase and evidence of oxidation activity in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am. Rev. Respir. Dis. 127:S25-7.
102. Lee CT, et al. (1981) Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome. N. Engl. J. Med. 304:192-6.
103. Donnelly SC, et al. (1995) Plasma elastase levels and the development of the adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 151:1428-33.
104. Zemans RL, Colgan SP, Downey GP. (2009) Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am. J. Respir. Cell Mol. Biol. 40:519-35.
105. Fujii M, et al. (2010) Effect of a neutrophil elas tase inhibitor on acute lung injury after cardiopulmonary bypass. Interact. Cardiovasc. Thorac. Surg. 10:859-62.
106. Inoue Y, et al. (2009) Development of a highly water-soluble peptide-based human neutrophil elastase inhibitor; AE-3763 for treatment of acute organ injury. Bioorg. Med. Chem. 17:7477-86.
107. Kawahara Y, et al. (2009) Prospective randomized controlled study on the effects of perioperative administration of a neutrophil elastase inhibitor to patients undergoing video-assisted thoracoscopic surgery for thoracic esophageal cancer. Dis. Esophagus.
108. Suda K, et al. (2007) Neutrophil elastase inhibitor improves postoperative clinical courses after thoracic esophagectomy. Dis. Esophagus 20:478-486.
109. Delacourt C, et al. (2002) Protection against acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor. Am. J. Respir. Cell Mol. Biol. 26:290-7.
110. Janusz MJ, Hare M. (1994) Inhibition of human neutrophil elastase and cathepsin G by a biphenyl disulfonic acid copolymer. Int. J. Immunopharmacol. 16:623-32.
111. Tremblay GM, Vachon E, Larouche C, Bourbonnais Y. (2002) Inhibition of human neutrophil elastase-induced acute lung injury in hamsters by recombinant human pre-elafin (trappin-2). Chest. 121:582-8.
112. Hagio T, et al. (2008) Inhibition of neutrophil elastase reduces lung injury and bacterial count in hamsters. Pulm. Pharmacol. Ther. 21:884-91.
113. Hagio T, Matsumoto S, Nakao S, Matsuoka S, Kawabata K. (2005) Sivelestat, a specific neutrophil elastase inhibitor, prevented phorbol myristate acetate-induced acute lung injury in conscious rabbits. Pulm Pharmacol. Ther. 18:285-90.
114. Kawabata K, et al. (2000) Delayed neutrophil elastase inhibition prevents subsequent progression of acute lung injury induced by endotoxin inhalation in hamsters. Am. J. Respir. Crit. Care Med. 161:2013-8.
115. Miyahara T, Kubo K, Koizumi T, Kobayashi T, Sekiguchi M. (1996) Specific neutrophil elastase inhibitor does not attenuate acute lung injury induced by air embolism in awake sheep. Exp. Lung Res. 22:613-25.
116. Sakamaki F, et al. (1996) Effect of a specific neutrophil elastase inhibitor, ONO-5046, on endotoxin- induced acute lung injury. Am. J. Respir. Crit. Care Med. 153:391-7.
117. Belaaouaj A, et al. (1998) Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat. Med. 4:615-8.
118. Ginzberg HH, et al. (2001) Neutrophil-mediated epithelial injury during transmigration: role of elastase. Am. J. Physiol. Gastrointest. Liver Physiol. 281: G705-17.
119. Carden D, et al. (1998) Neutrophil elastase promotes lung microvascular injury and proteolysis of endothelial cadherins. Am. J. Physiol. 275: H385-92.
120. Hirche TO, et al. (2004) Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain. J. Biol. Chem. 279:27688-98.
121. Rubio F, Cooley J, Accurso FJ, Remold-O'Donnell E. (2004) Linkage of neutrophil serine proteases and decreased surfactant protein-A (SPA) levels in inflammatory lung disease. Thorax. 59:318-23.
122. Vandivier RW, et al. (2002) Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J. Immunol. 169:3978-86.
123. Massberg S, et al. (2010) Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat. Med. 16:887-96.
124. Soehnlein O. (2009) An elegant defense: how neutrophils shape the immune response. Trends Immunol. 30:511-2.
125. Buczek-Thomas JA, et al. (2004) Elastase mediates the release of growth factors from lung in vivo. Am. J. Respir. Cell Mol. Biol. 31:344-50.
126. Chen HC, et al. (2004) Neutrophil elastase induces IL-8 synthesis by lung epithelial cells via the mitogen-activated protein kinase pathway. J. Biomed. Sci. 11:49-58.
127. Witherden IR, et al. (2004) Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. Am. J. Respir. Cell Mol. Biol. 30:500-9.
128. Suzuki T, et al. (2009) Leukocyte elastase induces lung epithelial apoptosis via a PAR-1-, NF-kappaB-, and p53-dependent pathway. Am. J. Respir. Cell Mol. Biol. 41:742-55.
129. Pham CT. (2006) Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 6:541-50.
130. Pham CT. (2008) Neutrophil serine proteases fine-tune the inflammatory response. Int. J. Biochem. Cell Biol. 40:1317-33.
131. Reeves EP, et al. (2002) Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature. 416:291-7.
132. Rochat T, Casale J, Hunninghake GW, Peterson MW. (1988) Neutrophil cathepsin G increases permeability of cultured type II pneumocytes. Am. J. Physiol. 255:C603-11.
133. Lucey EC, et al. (1985) Effect of combined human neutrophil cathepsin G and elastase on induction of secretory cell metaplasia and emphysema in hamsters, with in vitro observations on elastolysis by these enzymes. Am. Rev. Respir. Dis. 132:362-6.
134. Coyle AJ, Uchida D, Ackerman SJ, Mitzner W, Irvin CG. (1994) Role of cationic proteins in the airway. Hyperresponsiveness due to airway inflammation. Am. J. Respir. Crit. Care Med. 150:S63-71.
135. Onai H, Kudo S. (2001) Suppression of superantigen- induced lung injury and vasculitis by preadministration of human urinary trypsin inhibitor. Eur. J. Clin. Invest. 31:272-80.
136. Schreiber A, Busjahn A, Luft FC, Kettritz R. (2003) Membrane expression of proteinase 3 is genetically determined. J. Am. Soc. Nephrol. 14:68-75.
137. Hajjar E, Broemstrup T, Kantari C, Witko-Sarsat V, Reuter N. (2010) Structures of human proteinase 3 and neutrophil elastase-so similar yet so different. FEBS J. 277:2238-54.
138. Moriceau S, et al. (2009) Coronin-1 is associated with neutrophil survival and is cleaved during apoptosis: potential implication in neutrophils from cystic fibrosis patients. J. Immunol. 182:7254-63.
139. Meyer-Hoffert U. (2009) Neutrophil-derived serine proteases modulate innate immune responses. Front. Biosci. 14:3409-18.
140. Zani ML, Baranger K, Guyot N, Dallet-Choisy S, Moreau T. (2009) Protease inhibitors derived from elafin and SLPI and engineered to have enhanced specificity towards neutrophil serine proteases. Protein Sci. 18:579-94.
141. Plitas G, et al. (2003) Experimental hindlimb ischemia increases neutrophil-mediated matrix metalloproteinase activity: a potential mechanism for lung injury after limb ischemia. J. Am. Coll. Surg. 196:761-7.
142. Steinberg J, et al. (2003) Metalloproteinase inhibition reduces lung injury and improves survival after cecal ligation and puncture in rats. J. Surg. Res. 111:185-95.
143. Delclaux C, et al. (1997) Gelatinases in epithelial lining fluid of patients with adult respiratory distress syndrome. Am. J. Physiol. 272:L442-51.
144. Ricou B, et al. (1996) Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154:346-52.
145. Torii K, et al. (1997) Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 155:43-6.
146. Pugin J, Verghese G, Widmer MC, Matthay MA. (1999) The alveolar space is the site of intense inflammatory and profibrotic reactions in the early phase of acute respiratory distress syndrome. Crit. Care Med. 27:304-12.
147. Steinberg J, et al. (2001) Evidence of increased matrix metalloproteinase-9 concentration in patients following cardiopulmonary bypass. J. Extra Corpor. Technol. 33:218-22.
148. Fligiel SE, et al. (2006) Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury. Hum. Pathol. 37:422-30.
149. Kim JH, et al. (2006) Inhibition of matrix metalloproteinase- 9 prevents neutrophilic inflammation in ventilator-induced lung injury. Am. J. Physiol. Lung Cell. Mol, Physiol 291:L580-7.
150. Yoon HK, Cho HY, Kleeberger SR. (2007) Protective role of matrix metalloproteinase-9 in ozone-induced airway inflammation. Environ. Health Perspect. 115:1557-63.
151. Albaiceta GM, et al. (2008) Lack of matrix metalloproteinase- 9 worsens ventilator-induced lung injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 294:L535-43.
152. Albaiceta GM, et al. (2009) Absence or inhibition of matrix metalloproteinase-8 decreases ventilator- induced lung injury. Am. J. Respir. Cell Mol. Biol. 43:555-63.
153. Owen CA, Hu Z, Lopez-Otin C, Shapiro SD. (2004) Membrane-bound matrix metalloproteinase-8 on activated polymorphonuclear cells is a potent, tissue inhibitor of metalloproteinase-resistant collagenase and serpinase. J. Immunol. 172:7791-803.
154. Quintero PA, Knolle MD, Cala LF, Zhuang Y, Owen CA. (2010) Matrix metalloproteinase-8 inactivates macrophage inflammatory protein- 1{alpha} to reduce acute lung inflammation and injury in mice. J. Immunol. 184:1575-88.
155. Van Lint P, et al. (2005) Resistance of collagenase- 2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis. J. Immunol. 175:7642-9.
156. Balbin M, et al. (2003) Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat. Genet. 35:252-7.
157. Soehnlein O, Weber C, Lindbom L. (2009) Neutrophil granule proteins tune monocytic cell function. Trends Immunol. 30:538-46.
158. Yang D, de la Rosa G, Tewary P, Oppenheim JJ. (2009) Alarmins link neutrophils and dendritic cells. Trends Immunol. 30:531-7.
159. Levay PF, Viljoen M. (1995) Lactoferrin: a general review. Haematologica. 80:252-67.
160. Li KJ, et al. (2006) Release of surface-expressed lactoferrin from polymorphonuclear neutrophils after contact with CD4+ T cells and its modulation on Th1/Th2 cytokine production. J. Leukoc. Biol. 80:350-8.
161. Bournazou I, et al. (2009) Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin. J. Clin. Invest. 119:20-32.
162. de la Rosa G, Yang D, Tewary P, Varadhachary A, Oppenheim JJ. (2008) Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses. J. Immunol. 180:6868-76.
163. Actor JK, et al. (2002) Lactoferrin immunomodulation of DTH response in mice. Int. Immunopharmacol. 2:475-86.
164. Kruzel ML, et al. (2010) Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model. Innate Immun. 16:67-79.
165. Doss M, White MR, Tecle T, Hartshorn KL. (2010) Human defensins and LL-37 in mucosal immunity. J. Leukoc. Biol. 87:79-92.
166. Kai-Larsen Y, Agerberth B. (2008) The role of the multifunctional peptide LL-37 in host defense. Front Biosci. 13:3760-7.
167. Soehnlein O, et al. (2008) Neutrophil secretion products pave the way for inflammatory monocytes 165. Blood. 112:1461-71.
168. Fahy RJ, Wewers MD. (2005) Pulmonary defense and the human cathelicidin hCAP-18/LL-37. Immunol. Res. 31:75-89.
169. Scott MG, Davidson DJ, Gold MR, Bowdish D, Hancock REW. (2002) The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 169:3883-3891.
170. van der Does AM, et al. (2010) LL-37 Directs macrophage differentiation toward macrophages with a proinflammatory signature. J. Immunol. 185:1442-9.
171. Soehnlein O, Lindbom L. (2010) Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10:427-39.
172. Aarbiou J, et al. (2006) Mechanisms of cell death induced by the neutrophil antimicrobial peptides alpha-defensins and LL-37. Inflamm. Res. 55:119-27.
173. Barlow PG, et al. (2006) The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J. Leukoc. Biol. 80:509-20.
174. Nagaoka I, Tamura H, Hirata M. (2006) An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptorlike 1 and P2X7. J. Immunol. 176:3044-52.
175. Tecle T, Tripathi S, Hartshorn KL. (2010) Review: defensins and cathelicidins in lung immunity. Innate Immun. 16:151-9.
176. Ashitani J, et al. (2004) High concentrations of alpha-defensins in plasma and bronchoalveolar lavage fluid of patients with acute respiratory distress syndrome. Life Sci. 75:1123-34.
177. Soehnlein O, et al. (2008) Neutrophil primary granule proteins HBP and HNP1-3 boost bacterial phagocytosis by human and murine macrophages 168. J. Clin. Invest 118:3491-502.
178. Sakamoto N, et al. (2005) Differential effects of {alpha}- and {beta}-defensin on cytokine production by cultured human bronchial epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 288:L508-13.
179. Aarbiou J, et al. (2006) Mechanisms of cell death induced by the neutrophil antimicrobial peptides alpha-defensins and LL-37. Inflamm. Res. 55:119-27.
180. Nygaard SD, Ganz T, Peterson MW. (1993) Defensins reduce the barrier integrity of a cultured epithelial monolayer without cytotoxicity. Am. J. Respir. Cell Mol. Biol. 8:193-200.
181. Soong LB, Ganz T, Ellison A, Caughey GH. (1997) Purification and characterization of defensins from cystic fibrosis sputum. Inflamm. Res 46:98-102.
182. Van WS, Mannesse-Lazeroms SP, Dijkman JH, Hiemstra PS. (1997) Effect of neutrophil serine proteinases and defensins on lung epithelial cells: modulation of cytotoxicity and IL-8 production. J. Leukoc. Biol. 62:217-26.
183. Chertov O, et al. (1996) Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J. Biol. Chem. 271:2935-40.
184. Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J. (2007) Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J. Immunol. 179:3958-65.
185. Yang D, Chen Q, Chertov O, Oppenheim JJ. (2000) Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells. J. Leukoc. Biol. 68:9-14.
186. Bdeir K, et al. (2010) Neutrophil {alpha}-defensins cause lung injury by disrupting the capillaryepithelial barrier. Am. J. Respir. Crit. Care Med. 181:935-46.
187. Soehnlein O, Lindbom L. (2009) Neutrophilderived azurocidin alarms the immune system. J. Leukoc. Biol. 85:344-51.
188. Soehnlein O, et al. (2005) Neutrophil-derived heparin-binding protein (HBP/CAP37) deposited on endothelium enhances monocyte arrest under flow conditions 164. J. Immunol. 174:6399-405.
189. Gautam N, et al. (2001) Heparin-binding protein (HBP/CAP37): a missing link in neutrophilevoked alteration of vascular permeability. Nat. Med. 7:1123-7.
190. Di Gennaro A, et al. (2009) Leukotriene B4-induced changes in vascular permeability are mediated by neutrophil release of heparin-binding protein (HBP/CAP37/azurocidin). FASEB J. 23:1750-7.
191. Herwald H, et al. (2004) M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage. Cell. 116:367-79.
192. Yasui K, et al. (2008) Possible involvement of heparin- binding protein in transfusion-related acute lung injury. Transfusion. 48:978-87.
193. Johansson J, Lindbom L, Herwald H, Sjoberg F. (2009) Neutrophil-derived heparin binding protein-a mediator of increased vascular permeability after burns? Burns. 35:1185-7.
194. Linder A, Christensson B, Herwald H, Bjorck L, Akesson P. (2009) Heparin-binding protein: an early marker of circulatory failure in sepsis. Clin. Infect. Dis. 49:1044-50.
195. Linder A, Soehnlein O, Akesson P. (2010) Roles of heparin-binding protein in bacterial infections. J. Innate Immun. 2:431-8.
196. Fialkow L, Wang Y, Downey GP. (2007) Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic. Biol. Med. 42:153-64.
197. Liang B, Petty HR. (1992) Imaging neutrophil activation: analysis of the translocation and utilization of NAD(P)H-associated autofluorescence during antibody-dependent target oxidation. J. Cell Physiol. 152:145-56.
198. Lambeth JD. (2004) NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4:181-9.
199. Johnson KJ, Fantone JC, III, Kaplan J, Ward PA. (1981) In vivo damage of rat lungs by oxygen metabolites. J. Clin. Invest 67:983-93.
200. Auten RL, Whorton MH, Nicholas Mason S. (2002) Blocking neutrophil influx reduces DNA damage in hyperoxia-exposed newborn rat lung. Am. J. Respir. Cell. Mol. Biol. 26:391-7.
201. Auten RL Jr., Mason SN, Tanaka DT, Welty-Wolf K, Whorton MH. (2001) Anti-neutrophil chemokine preserves alveolar development in hyperoxia-exposed newborn rats. Am. J. Physiol. Lung Cell Mol. Physiol 281: L336-44.
202. Chiarugi P, et al. (2003) Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J. Cell Biol. 161:933-44.
203. Roper JM, et al. (2004) In vivo exposure to hyperoxia induces DNA damage in a population of alveolar type II epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 286:L1045-54.
204. Carnesecchi S, et al. (2009) NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. Am. J. Respir. Crit. Care Med. 180:972-81.
205. Kubo H, et al. (1996) Preservation of complementinduced lung injury in mice with deficiency of NADPH oxidase. J. Clin. Invest. 97:2680-4.
206. Wang W, Suzuki Y, Tanigaki T, Rank DR, Raffin TA. (1994) Effect of the NADPH oxidase inhibitor apocynin on septic lung injury in guinea pigs. Am. J. Respir. Crit. Care Med. 150:1449-52.
207. Kristof AS, Goldberg P, Laubach V, Hussain SN. (1998) Role of inducible nitric oxide synthase in endotoxin-induced acute lung injury. Am. J. Respir. Crit. Care Med. 158:1883-9.
208. Scheel-Toellner D, et al. (2004) Clustering of death receptors in lipid rafts initiates neutrophil spontaneous apoptosis. Biochem. Soc. Trans 32:679-81.
209. El Kebir D, Jozsef L, Pan W, Filep JG. (2008) Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation. Circ. Res. 103:352-9.
210. Ulbrich H, Eriksson EE, Lindbom L. (2003) Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease. Trends Pharmacol. Sci. 24:640-7.
211. Miller EJ, Cohen AB, Peterson BT. (1996) Peptide inhibitor of interleukin-8 (IL-8) reduces staphylococcal enterotoxin-A (SEA) induced neutrophil trafficking to the lung. Inflamm. Res. 45:393-7.
212. Hayashi S, Yatsunami J, Fukuno Y, Kawashima M, Miller EJ. (2002) Antileukinate, a hexapeptide inhibitor of CXC-chemokine receptor, suppresses bleomycin-induced acute lung injury in mice. Lung. 180:339-48.
213. Bhatia M, et al. (2000) Treatment with neutralising antibody against cytokine induced neutrophil chemoattractant (CINC) protects rats against acute pancreatitis associated lung injury. Gut. 47:838-44.
214. Kolb M, Margetts PJ, Anthony DC, Pitossi F, Gauldie J. (2001) Transient expression of IL-1b induces acute lung injury and chronic repair leading to pulmonary fibrosis. J. Clin. Invest. 107:1529-36.
215. Gerard C, et al. (1997) Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J. Clin. Invest. 100:2022-7.
216. Hirche TO, Atkinson JJ, Bahr S, Belaaouaj A. (2004) Deficiency in neutrophil elastase does not impair neutrophil recruitment to inflamed sites. Am. J. Respir. Cell Mol. Biol. 30:576-84.
217. Tkalcevic J, et al. (2000) Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity. 12:201-10.